MedPath

Effect of Remote Ischemic Preconditioning on Postoperative Complications in Visceral Surgery

Not Applicable
Conditions
Postoperative Complication
Interventions
Device: RIPC with a tourniquet
Registration Number
NCT02375269
Lead Sponsor
University of Zurich
Brief Summary

Remote Ischemic Preconditioning (RIPC) is mediated by intermittent brief episodes (5-10 minutes) of short ischemia in a limb (i.e. arm), followed by reperfusion. For this purpose in 3-4 cycles, a tourniquet is insufflated to suprasystolic pressure levels for 5 minutes and deflated for 5 minutes afterwards. The ischemic episodes are known to stimulate platelets and factors platelet dependent factors such as Serotonin and VEGF. These humoral factors have a systemic effect and have the potential to protect target organs (i.e. heart, kidney, liver) remote to the ischemic limb.

The purpose of this randomized controlled study is to investigate the influence and impact of RIPC on postoperative complications in patients undergoing visceral surgery

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
526
Inclusion Criteria
  • > 18 years
  • Undergoing major visceral surgery
Read More
Exclusion Criteria
  • < 18 years
  • Pregnancy
  • Signs of Infection/Inflammation on upper limb
  • Shunt
  • Medical history of axillary lymph node dissection
  • Signs of malperfusion of upper limb (i.e. Allen Test)
  • Missing informed consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RIPC (Remote Ischemic Preconditioning)RIPC with a tourniquetPreoperatively in the operation theater a tourniquet will be applied to the left arm and RIPC will performed. Therefore the tourniquet will be insufflated to suprasystolic pressure levels for 5 minutes, followed by 5 minutes reperfusion (deflated). Three cycles are planned. Duration of the procedure is 30 minutes.
Primary Outcome Measures
NameTimeMethod
Postoperative Complications30 days

Complications will be assessed by Comprehensive Complication Index and Dindo Clavien Score

Secondary Outcome Measures
NameTimeMethod
ICU stay30 days
Infection composite parameters30 days

CRP, Procalcitonin, Leucocytes

Hospital stay30 days

Trial Locations

Locations (1)

Department of Surgery, Swiss HPB and Transplant Surgery, University Hospital Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath